OTC advisory committee
This article was originally published in The Tan Sheet
Executive Summary
FDA's Nonprescription Drugs Advisory Committee is tentatively slated to next meet on Feb. 16-17. The committee was originally scheduled to convene in December ("The Tan Sheet" Sept. 27, p. 12), but that meeting has been canceled, in part, because of a backlog at the Office of OTC Drug Evaluation and the absence of OTC office Director Michael Weintraub, who suffered a stroke in September.